WO1993001745A1 - Measuring molecular change in the ocular lens - Google Patents
Measuring molecular change in the ocular lens Download PDFInfo
- Publication number
- WO1993001745A1 WO1993001745A1 PCT/US1992/005941 US9205941W WO9301745A1 WO 1993001745 A1 WO1993001745 A1 WO 1993001745A1 US 9205941 W US9205941 W US 9205941W WO 9301745 A1 WO9301745 A1 WO 9301745A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- patient
- approximately
- light
- radiation
- fluorescent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
- A61B3/117—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for examining the anterior chamber or the anterior chamber angle, e.g. gonioscopes
- A61B3/1173—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for examining the anterior chamber or the anterior chamber angle, e.g. gonioscopes for examining the eye lens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
Definitions
- This invention relates to evaluating changes in biological tissues and more specifically to apparatus and methods for quantitatively measuring molecular changes in the lens of the eye.
- ICA Islet Cell Antibody
- the ICA test is not typically utilized, however, because of its complexity, expense, and lack of specificity and because of a lack of standardization among evaluating laboratories.
- the test is useful only for detecting type I diabetes, which strikes only approximately ten percent of the entire diabetic patient population. By contrast, patients suspected of having the prediabetic condition for type II diabetes currently have no confirming diagnostic procedure.
- the lens of the eye can be made to fluoresce intensely when illuminated with radiation having a wavelength between approximately 350 nm and 550 ran. Utilizing radiation of a wavelength less than approximately 400 nm typically is avoided (unless power levels and exposure times are restricted), however, since this higher frequency radiation is known to cause damage to ocular tissue.
- the presence of certain diseases in the human body cause chemical changes in the lens of the eye, altering the amount of the fluorescent response to an illumination of the lens.
- the lenses of cataract patients for example, become opaque due to lipid peroxidation, protein glycosylation, and the conversion of sulfhydryl (- SH) bonds to disulfide bonds (SS).
- SS disulfide bonds
- the glucose and galactose are converted to sorbitol and dulcitol, respectively. Accumulation of these compounds results in a high osmotic gradient within the lenticular cells.
- Prolonged therapy with drugs such as corticosteroids and chlorpromazine also causes opacities of the human lens.
- the excitation wavelengths are selected from the ranges 320-340 nm, 380-390 nm, and 430-450 nm, while the intensity of fluorescence peaks is measured within wavelength ranges of 410- 440 nm, 450-460 nm, and 500-520 nm.
- the Lohmann patent measures the magnitude of fluorescence intensity at a single wavelength created by light of one excitation wavelength and compares this intensity to known intensities at the given wavelengths in order to determine the degree of eye lens cloudiness. Neither of these patents, however, teaches or suggests detection of diabetes or the prediabetic condition.
- the present invention provides apparatus and methods for noninvasively diagnosing selected diseases, including diabetes and the prediabetic condition and various diseases affecting metabolism, in tissues of humans or other animals.
- a narrow-band light source of wavelength typically between 400-1500 nm (and, preferably, approximately 406.7 nm) from a laser or similar device and a confocal lens system
- the present invention illuminates the ocular lens (or other) tissue and determines the intensity of the backscattered radiation at both the peak of the fluorescent response (typically at approximately 490 nm within the range 460-1800 nm) and the peak of the Rayleigh component (at the excitation wavelength).
- the detected radiation subsequently is transmitted to a spectrometer to be divided into its various components (e.g. fluorescence and Rayleigh).
- the intensity of the fluorescent component is then normalized to the intensity of the
- the relative amounts of the backscattered fluorescent and Rayleigh radiation provide a reliable indicator of the onset and progression of diseases such as (but not necessarily limited to) diabetes mellitus. the prediabetic condition, and cataracts in the human or other body.
- the present invention essentially eliminates the age-dependent measurement variations previously shown to be present.
- the precise amount of illumination energy delivered to the subject lens tissue area relative to the amount of fluorescence signal generated by the tissue can be determined.
- This approach reduces complications associated with variances in lens opacity which can alter, in an unknown fashion, the level of illumination delivered to the subject area.
- the technique permits establishment of a clear threshold- independent of age-separating the diabetic and prediabetic patients from those without the disease.
- the invention also neither requires use of a coherent light source nor suffers from the lack of specificity (existing in, e.g., the Weiss techniques) in discriminating the ultimate cause of the effect being measured.
- HG. 1 is a schematic representation of an apparatus of the present invention.
- HG. 2 is a schematic representation of an alternate embodiment of the apparatus of HG. 1.
- HG. 3 is a graphical representation of the fluorescent signal intensity as a function of age of both diabetic and nondiabetic patients obtained using the apparatus of HG. 1 as described in the EXAMPLE herein.
- HG. 4 is a graphical representation of the ratio of the fluorescent to Rayleigh signal intensities as a function of age of both diabetic and nondiabetic patients obtained using the apparatus of HG. 1 as described in the EXAMPLE herein.
- HG. 5 is a graphical representation of the fluorescent signal intensity as a function of age of both diabetic and nondiabetic patients obtained using the apparatus of HG. 1 for an illumination radiation wavelength outside a preferred range of that used in connection with the present invention.
- HG. 6 is a graphical representation of the ratio of the fluorescent to Rayleigh signal intensities as a function of age of both diabetic and nondiabetic patients obtained using the apparatus of HG. 1 for an illumination radiation wavelength outside a preferred range of that used in connection with the present invention.
- HG. 1 illustrates an optical system 5 of the present invention.
- Optical system 5 includes a light source 15, lens 25, a confocal lens system 35, collector 45, and a spectrometer 55.
- Source 15, which provides narrow-band illumination typically may be a low power krypton laser tuned to produce radiation having a wavelength between approximately 400-1500 nm. In one embodiment of optical system 5, source 15 provides radiation at a wavelength of 406.7 nm.
- ocular lens tissue L, attenuator 65, eyepiece 75, detection and processing assembly 85, and fiber optic waveguides 95 and 105 are also shown in HG. 1 ocular lens tissue L, attenuator 65, eyepiece 75, detection and processing assembly 85, and fiber optic waveguides 95 and 105.
- Attenuator 65 used to reduce the power level of the transmitted radiation, receives radiation from source 15 and forwards it to lens 25.
- Lens 25 which may be a 40X microscope objective or other similar device, then focuses the
- Lens system 35 subsequently delivers the radiation to a selected volume of ocular lens tissue L (typically approximately 200 cubic micrometers).
- a modified slit lamp base may be used to house and position lens system 35 for easy access to lens tissue L, while lens system 35 itself is designed to permit the same volume of lens tissue L to be held in the focal point of collector 45.
- the aperture 115 of lens system 35 at its focus is greater than approximately fifteen micrometers, ensuring that the excitation radiation diverges rapidly after passing through the focal point of lens system 35 and thereby reducing the spot intensity of the radiation should it encounter any other portions of the ocular tissue.
- Collector 45 receives the radiation backscattered from lens (or other) tissue L as a result of it being illuminated by radiation from source 15. From collector 45, the backscattered radiation is directed into waveguide 105 and transmitted to the entrance slit 125 of the monochromator 135 forming spectrometer 55. If desired, collector 45 also may direct a portion of the backscattered radiation to eyepiece 75, permitting an operator to view the exact location of the selected volume of lens tissue L.
- spectrometer 55 Division and processing of the backscattered radiation occurs in spectrometer 55 and detection and processing assembly 85. Radiation transmitted to spectrometer 55 initially is separated into its Rayleigh and florescence components. The two components subsequently are directed, respectively and as necessary, to amplifiers forming part of assembly 85, for determination of the intensities of each. Assembly 85 also may include a digital computer or similar computing device for forming the ratio of the fluorescent and Rayleigh components of the backscattered radiation, thereby no ⁇ nalizing the peak intensity of the fluorescent component.
- HG. 2 An alternate embodiment 10 of optical system 5 is illustrated in HG. 2.
- light source 20 which may be a laser diode, produces radiation of wavelength approximately 813.4 nm (within the range of approximately 800-860 nm) and is coupled to a nonlinear frequency doubling device 30 to produce the desired wavelength output of 406.7 nm (within the range 400-1500 nm).
- Light source 20 alternatively may be a laser, light emitting diode, or other narrow-band light source (including broadband sources coupled to optical filters).
- the radiation subsequently is directed through an optical delivery system 40 into the eye 50 of a patient.
- optical delivery system 40 As with the optical system 5 of HG.
- alternate embodiment 10 includes an optical collector 60 confocal to the delivery system 40 to collect the backscattered radiation from the lens of eye 50.
- the backscattered radiation collected includes both a fluorescence signal (typically approximately 490-500 nm within the range 460-1800 nm) and an intense Rayleigh component at the illumination wavelength.
- HG. 2 additionally discloses means for separating the components of interest of the backscattered radiation, including dichroic beam splitters 70 and 90, and for detecting the intensity of the components simultaneously using single chip silicon detectors 100 and 120 or similar devices. Alternatively, component separation may be accomplished using beam splitters in conjunction with optical bandpass filters or dispersive elements such as diffraction gratings. Hybrid detector/filter assemblies also may be used.
- Electronic circuitry 130 such as but neither limited to nor necessarily requiring analog amplifiers, analog to digital (A/D) converters, and a digital computer, processes the data detected by detectors 100 and 120, calculates the normalized fluorescent/Rayleigh component ratio, and, if desired, makes the result available to an operator through a digital display or other suitable means.
- Eyepiece 80 may be used by the operator to view the location of the excitation focal point in eye 50.
- the present invention may further be understood with reference to the following non-limiting EXAMPLE.
- EXAMPLE HGS. 3-6 illustrate data obtained from clinical trials conducted using sixty-nine (69) human patients aged twelve (12) to sixty-five (65). Forty-eight (48) of the patients had previously been diagnosed as having diabetes, while the remaining twenty-one (21) had not.
- HGS. 3 shows the total fluorescence signal obtained for each patient (expressed in "Counts x 10 s ,” where the number of Counts is a function of the number of emitted photons per unit time) using an illumination wavelength of 406.7 nm.
- HG. 4 details the results when those same fluorescence signals are normalized by the Rayleigh component of the backscattered radiation in accordance with the present invention. As illustrated in HG.
- HGS. 5-6 which correspond, respectively, to HGS. 3-4, show (in HG. 6) less of a distinction between the normalized signals for the diabetic as opposed to nondiabetic patients.
- those patients who tested ICA positive are shown to have fluorescent/Rayleigh ratios within the range of nondiabetic patient values.
- no clearly established threshold is available for diagnostic purposes.
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5502944A JPH07500030A (en) | 1991-07-17 | 1992-07-16 | Measuring molecular changes in the eye lens |
EP92916422A EP0597932B1 (en) | 1991-07-17 | 1992-07-16 | Measuring molecular change in the ocular lens |
DE69222535T DE69222535T2 (en) | 1991-07-17 | 1992-07-16 | DETECTION OF MOLECULAR CHANGES IN THE EYE LENS |
AU23733/92A AU661026B2 (en) | 1991-07-17 | 1992-07-16 | Measuring molecular change in the ocular lens |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/731,533 US5203328A (en) | 1991-07-17 | 1991-07-17 | Apparatus and methods for quantitatively measuring molecular changes in the ocular lens |
US731,533 | 1991-07-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1993001745A1 true WO1993001745A1 (en) | 1993-02-04 |
Family
ID=24939928
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1992/005941 WO1993001745A1 (en) | 1991-07-17 | 1992-07-16 | Measuring molecular change in the ocular lens |
Country Status (9)
Country | Link |
---|---|
US (2) | US5203328A (en) |
EP (1) | EP0597932B1 (en) |
JP (1) | JPH07500030A (en) |
AT (1) | ATE158704T1 (en) |
AU (1) | AU661026B2 (en) |
CA (1) | CA2113268C (en) |
DE (1) | DE69222535T2 (en) |
ES (1) | ES2110007T3 (en) |
WO (1) | WO1993001745A1 (en) |
Cited By (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994023284A1 (en) * | 1993-04-06 | 1994-10-13 | Cedar-Sinai Medical Center | Glucose fluorescence monitor and method |
WO1995022927A1 (en) * | 1994-02-23 | 1995-08-31 | Peyman Gholam A | Diagnostic system and method using an implanted reflective device |
WO1997013448A2 (en) * | 1995-10-14 | 1997-04-17 | Laser- Und Medizin-Technologie Gmbh Berlin | Device for determining blood glucose level |
WO1997020495A1 (en) * | 1995-12-01 | 1997-06-12 | Cedars-Sinai Medical Center | Glucose monitoring apparatus and method using laser-induced emission spectroscopy |
US5701902A (en) * | 1994-09-14 | 1997-12-30 | Cedars-Sinai Medical Center | Spectroscopic burn injury evaluation apparatus and method |
WO2001013783A1 (en) * | 1999-08-26 | 2001-03-01 | Novartis Ag | Ocular analyte sensor |
EP1229836A1 (en) * | 1999-11-05 | 2002-08-14 | SPECTRX, Inc. | Multi-modal optical tissue diagnostic system |
US7041063B2 (en) | 1996-09-04 | 2006-05-09 | Marcio Marc Abreu | Noninvasive measurement of chemical substances |
US7187960B2 (en) | 2002-04-22 | 2007-03-06 | Marcio Marc Abreu | Apparatus and method for measuring biologic parameters |
WO2009083159A1 (en) * | 2007-12-21 | 2009-07-09 | Carl Zeiss Meditec Ag | Device and method for detection of molecules in the eye |
US8328420B2 (en) | 2003-04-22 | 2012-12-11 | Marcio Marc Abreu | Apparatus and method for measuring biologic parameters |
JP2014504169A (en) * | 2010-11-05 | 2014-02-20 | フリーダム メディテック インコーポレイテッド | Improved algorithm for diabetes detection |
US8849379B2 (en) | 2002-04-22 | 2014-09-30 | Geelux Holdings, Ltd. | Apparatus and method for measuring biologic parameters |
US9119530B2 (en) | 2005-10-24 | 2015-09-01 | Geelux Holdings, Ltd. | Apparatus and method for measuring biologic parameters |
US9442065B2 (en) | 2014-09-29 | 2016-09-13 | Zyomed Corp. | Systems and methods for synthesis of zyotons for use in collision computing for noninvasive blood glucose and other measurements |
US9554738B1 (en) | 2016-03-30 | 2017-01-31 | Zyomed Corp. | Spectroscopic tomography systems and methods for noninvasive detection and measurement of analytes using collision computing |
US9848815B2 (en) | 2002-04-22 | 2017-12-26 | Geelux Holdings, Ltd. | Apparatus and method for measuring biologic parameters |
US10227063B2 (en) | 2004-02-26 | 2019-03-12 | Geelux Holdings, Ltd. | Method and apparatus for biological evaluation |
US10238847B2 (en) | 2014-01-22 | 2019-03-26 | Geelux Holdings, Ltd. | Devices and methods for transdermal drug delivery |
US10251776B2 (en) | 2014-01-10 | 2019-04-09 | Geelux Holding, Ltd. | Devices configured to monitor biological parameters, and to provide treatment, at an Abreu brain thermal tunnel |
US10335040B2 (en) | 2014-01-10 | 2019-07-02 | Geelux Holdings, Ltd. | Device for measuring the infrared output of the Abreu brain thermal tunnel |
US11497405B2 (en) | 2013-10-11 | 2022-11-15 | Brain Tunnelgenix Technologies Corp. | Method and apparatus for biological evaluation |
US11872018B2 (en) | 2015-03-10 | 2024-01-16 | Brain Tunnelgenix Technologies Corp. | Devices, apparatuses, systems, and methods for measuring temperature of an ABTT terminus |
Families Citing this family (138)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5203328A (en) * | 1991-07-17 | 1993-04-20 | Georgia Tech Research Corporation | Apparatus and methods for quantitatively measuring molecular changes in the ocular lens |
DE4243142A1 (en) * | 1992-12-19 | 1994-06-23 | Boehringer Mannheim Gmbh | Device for in-vivo determination of an optical property of the aqueous humor of the eye |
US5427094A (en) * | 1993-11-08 | 1995-06-27 | Oculon Corporation | Method and apparatus for detecting cataractogenesis |
US5427095A (en) * | 1993-11-09 | 1995-06-27 | Massachusetts Institute of Technology Oculon Corporation | Method and apparatus for detecting cataractogenesis |
US5685313A (en) * | 1994-05-31 | 1997-11-11 | Brain Monitor Ltd. | Tissue monitor |
EP0785747A1 (en) * | 1995-03-23 | 1997-07-30 | Koninklijke Philips Electronics N.V. | Device for carrying out optical measurements in turbid media |
US7328059B2 (en) | 1996-08-23 | 2008-02-05 | The Texas A & M University System | Imaging of light scattering tissues with fluorescent contrast agents |
US6002954A (en) * | 1995-11-22 | 1999-12-14 | The Regents Of The University Of California | Detection of biological molecules using boronate-based chemical amplification and optical sensors |
WO1997019188A1 (en) | 1995-11-22 | 1997-05-29 | Minimed, Inc. | Detection of biological molecules using chemical amplification and optical sensors |
US6766183B2 (en) | 1995-11-22 | 2004-07-20 | Medtronic Minimed, Inc. | Long wave fluorophore sensor compounds and other fluorescent sensor compounds in polymers |
US5882301A (en) | 1995-12-13 | 1999-03-16 | Yoshida; Akitoshi | Measuring apparatus for intraocular substance employing light from eyeball |
KR19990076724A (en) * | 1996-01-26 | 1999-10-15 | 로셰 디아그노스틱스 게엠베하 | Methods and apparatus for measuring analytes contained in a scattering matrix |
WO1998022820A1 (en) | 1996-11-21 | 1998-05-28 | Lawrence Livermore National Laboratory | Detection of biological molecules using boronate-based chemical amplification and optical sensors |
CA2192036A1 (en) * | 1996-12-04 | 1998-06-04 | Harvey Lui | Fluorescence scope system for dermatologic diagnosis |
US6826422B1 (en) | 1997-01-13 | 2004-11-30 | Medispectra, Inc. | Spectral volume microprobe arrays |
US6847490B1 (en) | 1997-01-13 | 2005-01-25 | Medispectra, Inc. | Optical probe accessory device for use in vivo diagnostic procedures |
US7865230B1 (en) | 1997-02-07 | 2011-01-04 | Texas A&M University System | Method and system for detecting sentinel lymph nodes |
US5880812A (en) * | 1997-03-13 | 1999-03-09 | Ramot-University Authority For Applied Research And Industrial Development, Ltd. | Method and apparatus for evaluating and mapping visual field |
JP4383545B2 (en) | 1997-03-19 | 2009-12-16 | ルーシド インコーポレーテッド | Cell surgery using confocal microscopy |
US6091984A (en) * | 1997-10-10 | 2000-07-18 | Massachusetts Institute Of Technology | Measuring tissue morphology |
ATE352252T1 (en) | 1997-11-12 | 2007-02-15 | Lightouch Medical Inc | METHOD FOR NON-INVASIVE ANALYTE MEASUREMENT |
US6070093A (en) | 1997-12-02 | 2000-05-30 | Abbott Laboratories | Multiplex sensor and method of use |
US6055451A (en) | 1997-12-12 | 2000-04-25 | Spectrx, Inc. | Apparatus and method for determining tissue characteristics |
DE19808779C1 (en) * | 1998-03-03 | 1999-10-28 | Paul Dobrinski | Cataract measuring device for eye of patient |
US6174291B1 (en) | 1998-03-09 | 2001-01-16 | Spectrascience, Inc. | Optical biopsy system and methods for tissue diagnosis |
US6560478B1 (en) * | 1998-03-16 | 2003-05-06 | The Research Foundation Of City University Of New York | Method and system for examining biological materials using low power CW excitation Raman spectroscopy |
US5919132A (en) * | 1998-03-26 | 1999-07-06 | Universite De Montreal | On-line and real-time spectroreflectometry measurement of oxygenation in a patient's eye |
US6149589A (en) * | 1998-03-26 | 2000-11-21 | Universite De Montreal | On-line and real-time spectroreflectometry measurement of oxygenation in a patient's eye |
ATE225142T1 (en) | 1998-07-07 | 2002-10-15 | Lightouch Medical Inc | TISSUE MODULATION METHOD FOR QUANTITATIVE NON-INVASIVE IN VIVO SPECTROSCOPIC ANALYSIS OF TISSUE |
EP1112022A4 (en) * | 1998-09-11 | 2004-08-04 | Spectrx Inc | Multi-modal optical tissue diagnostic system |
US6708060B1 (en) * | 1998-11-09 | 2004-03-16 | Transpharma Ltd. | Handheld apparatus and method for transdermal drug delivery and analyte extraction |
US6597946B2 (en) | 1998-11-09 | 2003-07-22 | Transpharma Ltd. | Electronic card for transdermal drug delivery and analyte extraction |
US6611706B2 (en) | 1998-11-09 | 2003-08-26 | Transpharma Ltd. | Monopolar and bipolar current application for transdermal drug delivery and analyte extraction |
US6148232A (en) | 1998-11-09 | 2000-11-14 | Elecsys Ltd. | Transdermal drug delivery and analyte extraction |
US6721583B1 (en) * | 1998-11-19 | 2004-04-13 | The United States Of America | Method for non-invasive identification of individuals at risk for diabetes |
WO2000037917A2 (en) | 1998-12-23 | 2000-06-29 | Medispectra, Inc. | Systems and methods for optical examination of samples |
CA2356195A1 (en) * | 1998-12-23 | 2000-06-29 | Medispectra, Inc. | Optical methods and systems for cervical screening |
US6404497B1 (en) | 1999-01-25 | 2002-06-11 | Massachusetts Institute Of Technology | Polarized light scattering spectroscopy of tissue |
US6665556B1 (en) * | 1999-01-29 | 2003-12-16 | Robert R. Alfano | Method and apparatus for examining a tissue using the spectral wing emission therefrom induced by visible to infrared photoexcitation |
US6088606A (en) * | 1999-03-22 | 2000-07-11 | Spectrx, Inc. | Method and apparatus for determining a duration of a medical condition |
US6219566B1 (en) * | 1999-07-13 | 2001-04-17 | Photonics Research Ontario | Method of measuring concentration of luminescent materials in turbid media |
US6673625B2 (en) | 1999-09-15 | 2004-01-06 | The Regents Of The University Of California | Saccharide sensing molecules having enhanced fluorescent properties |
US6682938B1 (en) | 1999-09-15 | 2004-01-27 | The Regents Of The University Of California | Glucose sensing molecules having selected fluorescent properties |
US6494576B1 (en) | 1999-09-30 | 2002-12-17 | L'esperance, Jr. Francis A. | Method and apparatus for spectrophotometry of the eye |
US7054002B1 (en) | 1999-10-08 | 2006-05-30 | The Texas A&M University System | Characterization of luminescence in a scattering medium |
US7187810B2 (en) * | 1999-12-15 | 2007-03-06 | Medispectra, Inc. | Methods and systems for correcting image misalignment |
US7260248B2 (en) * | 1999-12-15 | 2007-08-21 | Medispectra, Inc. | Image processing using measures of similarity |
US6902935B2 (en) * | 1999-12-15 | 2005-06-07 | Medispectra, Inc. | Methods of monitoring effects of chemical agents on a sample |
US6377841B1 (en) * | 2000-03-31 | 2002-04-23 | Vanderbilt University | Tumor demarcation using optical spectroscopy |
US20040044287A1 (en) * | 2000-03-31 | 2004-03-04 | Wei-Chiang Lin | Identification of human tissue using optical spectroscopy |
ATE417543T1 (en) * | 2000-07-13 | 2009-01-15 | Univ Virginia Commonwealth | USE OF ULTRAVIOLET, NEAR ULTRAVIOLET AND NEAR INFRARED RESONANCE RMAN SPECTROSCOPY AND FLUORESENSENCE SPECTOSCOPY FOR EXAMINING TISSUE FOR SHOCK, CRITICAL ILLNESSES OR OTHER MEDICAL CONDITIONS |
US6549861B1 (en) | 2000-08-10 | 2003-04-15 | Euro-Celtique, S.A. | Automated system and method for spectroscopic analysis |
WO2002016905A2 (en) | 2000-08-21 | 2002-02-28 | Euro-Celtique, S.A. | Near infrared blood glucose monitoring system |
IL155837A0 (en) | 2000-11-16 | 2004-06-01 | Chameleon Medical Innovation L | A diagnostic system for the ear |
US6839661B2 (en) * | 2000-12-15 | 2005-01-04 | Medispectra, Inc. | System for normalizing spectra |
US6697652B2 (en) | 2001-01-19 | 2004-02-24 | Massachusetts Institute Of Technology | Fluorescence, reflectance and light scattering spectroscopy for measuring tissue |
AU2002251944A1 (en) * | 2001-02-15 | 2002-09-04 | Medtronic Minimed, Inc. | Polymers functionalized with fluorescent boronate motifs |
US7139598B2 (en) * | 2002-04-04 | 2006-11-21 | Veralight, Inc. | Determination of a measure of a glycation end-product or disease state using tissue fluorescence |
US7043288B2 (en) * | 2002-04-04 | 2006-05-09 | Inlight Solutions, Inc. | Apparatus and method for spectroscopic analysis of tissue to detect diabetes in an individual |
US20070276199A1 (en) * | 2002-04-04 | 2007-11-29 | Ediger Marwood N | Determination of a Measure of a Glycation End-Product or Disease State Using Tissue Fluorescence |
CA2441787C (en) * | 2001-04-27 | 2011-08-09 | Novartis Ag | Apparatus for measuring blood glucose concentrations |
US7904176B2 (en) * | 2006-09-07 | 2011-03-08 | Bio Control Medical (B.C.M.) Ltd. | Techniques for reducing pain associated with nerve stimulation |
US7045361B2 (en) | 2001-09-12 | 2006-05-16 | Medtronic Minimed, Inc. | Analyte sensing via acridine-based boronate biosensors |
US6650915B2 (en) | 2001-09-13 | 2003-11-18 | Fovioptics, Inc. | Non-invasive measurement of blood analytes using photodynamics |
US8308797B2 (en) * | 2002-01-04 | 2012-11-13 | Colibri Heart Valve, LLC | Percutaneously implantable replacement heart valve device and method of making same |
US8140147B2 (en) * | 2002-04-04 | 2012-03-20 | Veralight, Inc. | Determination of a measure of a glycation end-product or disease state using a flexible probe to determine tissue fluorescence of various sites |
US8131332B2 (en) * | 2002-04-04 | 2012-03-06 | Veralight, Inc. | Determination of a measure of a glycation end-product or disease state using tissue fluorescence of various sites |
US7725144B2 (en) * | 2002-04-04 | 2010-05-25 | Veralight, Inc. | Determination of disease state using raman spectroscopy of tissue |
US20120078075A1 (en) * | 2002-04-04 | 2012-03-29 | Maynard John D | Determination of a measure of a glycation end-product or disease state using tissue fluorescence in combination with one or more other tests |
AU2003226605A1 (en) * | 2002-04-19 | 2003-11-03 | Transpharma Medical Ltd. | Handheld transdermal drug delivery and analyte extraction |
US6933154B2 (en) * | 2002-07-09 | 2005-08-23 | Medispectra, Inc. | Optimal windows for obtaining optical data for characterization of tissue samples |
US7459696B2 (en) | 2003-04-18 | 2008-12-02 | Schomacker Kevin T | Methods and apparatus for calibrating spectral data |
US7469160B2 (en) * | 2003-04-18 | 2008-12-23 | Banks Perry S | Methods and apparatus for evaluating image focus |
US20040208385A1 (en) * | 2003-04-18 | 2004-10-21 | Medispectra, Inc. | Methods and apparatus for visually enhancing images |
US7136518B2 (en) * | 2003-04-18 | 2006-11-14 | Medispectra, Inc. | Methods and apparatus for displaying diagnostic data |
US6818903B2 (en) * | 2002-07-09 | 2004-11-16 | Medispectra, Inc. | Method and apparatus for identifying spectral artifacts |
US20040209237A1 (en) * | 2003-04-18 | 2004-10-21 | Medispectra, Inc. | Methods and apparatus for characterization of tissue samples |
US7282723B2 (en) * | 2002-07-09 | 2007-10-16 | Medispectra, Inc. | Methods and apparatus for processing spectral data for use in tissue characterization |
US7309867B2 (en) | 2003-04-18 | 2007-12-18 | Medispectra, Inc. | Methods and apparatus for characterization of tissue samples |
US20040208390A1 (en) * | 2003-04-18 | 2004-10-21 | Medispectra, Inc. | Methods and apparatus for processing image data for use in tissue characterization |
US6768918B2 (en) * | 2002-07-10 | 2004-07-27 | Medispectra, Inc. | Fluorescent fiberoptic probe for tissue health discrimination and method of use thereof |
US7103401B2 (en) | 2002-07-10 | 2006-09-05 | Medispectra, Inc. | Colonic polyp discrimination by tissue fluorescence and fiberoptic probe |
US6895264B2 (en) | 2002-08-26 | 2005-05-17 | Fovioptics Inc. | Non-invasive psychophysical measurement of glucose using photodynamics |
WO2004060154A1 (en) * | 2003-01-07 | 2004-07-22 | Intelligent Photonics Control Corp. | Non-invasive blood monitor |
WO2004113889A1 (en) * | 2003-06-20 | 2004-12-29 | The Texas A & M University System | Method and system for near-infrared fluorescence contrast-enhanced imaging with area illumination and area detection |
US7356365B2 (en) * | 2003-07-09 | 2008-04-08 | Glucolight Corporation | Method and apparatus for tissue oximetry |
US20050090723A1 (en) * | 2003-10-23 | 2005-04-28 | Nassar Saeed | Method and apparatus for non-invasive measuring of physiological glucose concentration in bodies of humans or animals |
GB2407378B (en) | 2003-10-24 | 2006-09-06 | Lein Applied Diagnostics Ltd | Ocular property measuring apparatus and method therefor |
CN100998499B (en) * | 2003-10-28 | 2013-07-24 | 薇拉莱特公司 | Determination of a measure of a glycation end-product or disease state using tissue fluorescence |
WO2005050156A2 (en) * | 2003-11-18 | 2005-06-02 | Chameleon Medical Innovation Ltd. | Measurement system and method for use in determining the patient's condition |
GB2409033C (en) * | 2003-12-12 | 2006-05-24 | Lein Applied Diagnostics Ltd | Extended focal region measuring apparatus and method |
US7510849B2 (en) * | 2004-01-29 | 2009-03-31 | Glucolight Corporation | OCT based method for diagnosis and therapy |
US7254429B2 (en) | 2004-08-11 | 2007-08-07 | Glucolight Corporation | Method and apparatus for monitoring glucose levels in a biological tissue |
US8036727B2 (en) | 2004-08-11 | 2011-10-11 | Glt Acquisition Corp. | Methods for noninvasively measuring analyte levels in a subject |
US7822452B2 (en) | 2004-08-11 | 2010-10-26 | Glt Acquisition Corp. | Method for data reduction and calibration of an OCT-based blood glucose monitor |
US7330746B2 (en) * | 2005-06-07 | 2008-02-12 | Chem Image Corporation | Non-invasive biochemical analysis |
US7330747B2 (en) * | 2005-06-07 | 2008-02-12 | Chemimage Corporation | Invasive chemometry |
CA2616376A1 (en) * | 2005-07-25 | 2007-02-01 | Duke University | Methods, systems, and computer program products for optimization of probes for spectroscopic measurement in turbid media |
US20070167835A1 (en) * | 2005-07-25 | 2007-07-19 | Massachusetts Institute Of Technology | Tri modal spectroscopic imaging |
US20070173736A1 (en) * | 2005-10-07 | 2007-07-26 | Femspec Llc | Apparatus and methods for endometrial biopsies |
JP2009520547A (en) * | 2005-12-22 | 2009-05-28 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | Device for controlled release of chemical molecules |
EP2001352A4 (en) * | 2006-03-17 | 2010-04-07 | Univ Duke | Monte carlo based model of fluorescence in turbid media and methods and systems for using same to determine intrinsic fluorescence of turbid media |
US7751039B2 (en) * | 2006-03-30 | 2010-07-06 | Duke University | Optical assay system for intraoperative assessment of tumor margins |
WO2008052221A2 (en) * | 2006-10-27 | 2008-05-02 | Aretais, Inc. | Use of coherent raman techniques for medical diagnostic and therapeutic purposes, and calibration techniques for same |
US8498695B2 (en) | 2006-12-22 | 2013-07-30 | Novadaq Technologies Inc. | Imaging system with a single color image sensor for simultaneous fluorescence and color video endoscopy |
JP2008197088A (en) * | 2007-01-19 | 2008-08-28 | Shimadzu Corp | Fluorescent detector |
WO2008103486A1 (en) * | 2007-02-23 | 2008-08-28 | Duke University | Scaling method for fast monte carlo simulation of diffuse reflectance spectra |
GB2451442B (en) * | 2007-07-30 | 2013-03-06 | Lein Applied Diagnostics Ltd | Optical measurement apparatus and method therefor |
GB2451443B (en) | 2007-07-30 | 2012-12-26 | Lein Applied Diagnostics Ltd | Optical measurement apparatus and method therefor |
WO2009043050A2 (en) * | 2007-09-27 | 2009-04-02 | Duke University | Optical assay system with a multi-probe imaging array |
WO2009043045A1 (en) * | 2007-09-28 | 2009-04-02 | Duke University | Systems and methods for spectral analysis of a tissue mass using an instrument, an optical probe, and a monte carlo or a diffusion algorithm |
EP2057941A1 (en) * | 2007-11-07 | 2009-05-13 | Koninklijke Philips Electronics N.V. | Method and device for imaging an interior of an optically turbid medium |
US8986253B2 (en) | 2008-01-25 | 2015-03-24 | Tandem Diabetes Care, Inc. | Two chamber pumps and related methods |
GB2457302B (en) | 2008-02-11 | 2013-04-10 | Lein Applied Diagnostics Ltd | Measurement apparatus and method therefor |
US8768423B2 (en) | 2008-03-04 | 2014-07-01 | Glt Acquisition Corp. | Multispot monitoring for use in optical coherence tomography |
JP5094484B2 (en) * | 2008-03-11 | 2012-12-12 | 富士フイルム株式会社 | Fluorescence detection method and fluorescence detection apparatus |
JP5097590B2 (en) * | 2008-03-26 | 2012-12-12 | 富士フイルム株式会社 | Raman signal measuring method and Raman signal measuring apparatus |
US20110105865A1 (en) * | 2008-04-24 | 2011-05-05 | Duke University | Diffuse reflectance spectroscopy device for quantifying tissue absorption and scattering |
US8408421B2 (en) | 2008-09-16 | 2013-04-02 | Tandem Diabetes Care, Inc. | Flow regulating stopcocks and related methods |
US8650937B2 (en) | 2008-09-19 | 2014-02-18 | Tandem Diabetes Care, Inc. | Solute concentration measurement device and related methods |
US20100249607A1 (en) * | 2008-09-26 | 2010-09-30 | Massachusetts Institute Of Technology | Quantitative spectroscopic imaging |
US8606366B2 (en) | 2009-02-18 | 2013-12-10 | Syneron Medical Ltd. | Skin treatment apparatus for personal use and method for using same |
GB0903274D0 (en) | 2009-02-26 | 2009-04-08 | Edinburgh Instr | Fluoreence method and system |
US7896498B2 (en) * | 2009-03-30 | 2011-03-01 | Ottawa Hospital Research Institute | Apparatus and method for optical measurements |
EP2724739B1 (en) | 2009-07-30 | 2015-07-01 | Tandem Diabetes Care, Inc. | Portable infusion pump system |
EP2467805B1 (en) | 2009-08-20 | 2020-08-05 | Koninklijke Philips N.V. | Method and system for image analysis |
BR112012007924A2 (en) * | 2009-10-06 | 2020-08-18 | Koninklijke Philips Electronics N. V | remote photoplethysmography method and system for performing remote photoplethysmography |
US9091637B2 (en) | 2009-12-04 | 2015-07-28 | Duke University | Smart fiber optic sensors systems and methods for quantitative optical spectroscopy |
SG10201501500TA (en) | 2010-03-01 | 2015-04-29 | Colibri Heart Valve Llc | Percutaneously deliverable heart valve and methods associated therewith |
CA2806544C (en) | 2010-06-28 | 2016-08-23 | Colibri Heart Valve Llc | Method and apparatus for the endoluminal delivery of intravascular devices |
AU2015202762B2 (en) * | 2010-11-05 | 2017-04-20 | Sinocare Meditech, Inc. | Improved algorithm for detection of diabetes |
JP2014507179A (en) | 2010-12-14 | 2014-03-27 | コリブリ ハート バルブ エルエルシー | Percutaneously deliverable heart valve including folded membrane cusps with integrated leaflets |
US9180242B2 (en) | 2012-05-17 | 2015-11-10 | Tandem Diabetes Care, Inc. | Methods and devices for multiple fluid transfer |
US9173998B2 (en) | 2013-03-14 | 2015-11-03 | Tandem Diabetes Care, Inc. | System and method for detecting occlusions in an infusion pump |
WO2017079844A1 (en) * | 2015-11-13 | 2017-05-18 | Novadaq Technologies Inc. | Systems and methods for illumination and imaging of a target |
US10869645B2 (en) | 2016-06-14 | 2020-12-22 | Stryker European Operations Limited | Methods and systems for adaptive imaging for low light signal enhancement in medical visualization |
WO2018003906A1 (en) * | 2016-06-30 | 2018-01-04 | 興和株式会社 | Ophthalmic measurement device |
US11395726B2 (en) | 2017-09-11 | 2022-07-26 | Incubar Llc | Conduit vascular implant sealing device for reducing endoleaks |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4548498A (en) * | 1981-05-04 | 1985-10-22 | Folestad Sven S | Laser induced fluorescence detection in modern liquid chromatography with conventional and micro columns |
US4592361A (en) * | 1982-06-28 | 1986-06-03 | The Johns Hopkins University | Electro-optical device and method for monitoring instantaneous singlet oxygen concentration produced during photoradiation using pulsed excitation and time domain signal processing |
US4675300A (en) * | 1985-09-18 | 1987-06-23 | The Board Of Trustees Of The Leland Stanford Junior University | Laser-excitation fluorescence detection electrokinetic separation |
US4758081A (en) * | 1985-07-18 | 1988-07-19 | Bausch & Lomb Incorporated | Control of laser photocoagulation using Raman radiation |
US4883351A (en) * | 1982-09-10 | 1989-11-28 | Weiss Jeffrey N | Apparatus for the detection of diabetes and other abnormalities affecting the lens of the eye |
US4895159A (en) * | 1982-09-10 | 1990-01-23 | Weiss Jeffrey N | Diabetes detection method |
Family Cites Families (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1531145A (en) * | 1966-07-13 | 1968-06-28 | Ici Ltd | Polyamides |
US3948248A (en) * | 1974-09-05 | 1976-04-06 | Zuckerman Joel L | Method of measuring ocular pulse |
US3958560A (en) * | 1974-11-25 | 1976-05-25 | Wayne Front March | Non-invasive automatic glucose sensor system |
US4014321A (en) * | 1974-11-25 | 1977-03-29 | March Wayne F | Non-invasive glucose sensor system |
DE2619571A1 (en) * | 1976-05-04 | 1977-11-17 | Dynamit Nobel Ag | Acylase enzyme immobilisation - on lamellar aluminium hydrosilicates modified with amino-silanes |
US4350163A (en) * | 1980-05-29 | 1982-09-21 | Ford Jr Norman C | Method and apparatus for analyzing contaminants in aqueous humor |
US4412543A (en) * | 1981-04-09 | 1983-11-01 | Xanar, Inc. | Apparatus for determining the concentration of a fluorescent material in an eye |
US5025785A (en) * | 1982-09-10 | 1991-06-25 | Weiss Jeffrey N | Diabetes detection method |
US4573778A (en) * | 1983-03-16 | 1986-03-04 | Boston University | Aqueous fluorophotometer |
DE3331586A1 (en) * | 1983-09-01 | 1985-03-28 | Fa. Carl Zeiss, 7920 Heidenheim | OPHTHALMOLOGICAL COMBINATION DEVICE FOR DIAGNOSIS AND THERAPY |
DE3346338A1 (en) * | 1983-12-22 | 1985-07-11 | Pka Pyrolyse Kraftanlagen Gmbh, 7080 Aalen | ROTATING SUSPENSION DRUM FOR SUSPENSIONING WASTE |
US4711540A (en) * | 1984-01-04 | 1987-12-08 | Tokyo Kogaku Kikai Kabushiki Kaisha | Eye disease inspecting instrument |
JPS60148537A (en) * | 1984-01-12 | 1985-08-05 | 興和株式会社 | Opththalimic measuring apparatus utilizing laser beam |
US4711541A (en) * | 1984-02-02 | 1987-12-08 | Tokyo Kogaku Kikai Kabushiki Kaisha | Slit lamp and accessory device thereof |
JPS61243827A (en) * | 1985-04-22 | 1986-10-30 | Toray Ind Inc | Production of nylon 66 polymer for high-speed spinning |
JPS61268230A (en) * | 1985-05-22 | 1986-11-27 | 興和株式会社 | Ophthalmic measuring apparatus |
JPS61268229A (en) * | 1985-05-22 | 1986-11-27 | 興和株式会社 | Ophthalmic measuring apparatus |
US4702576A (en) * | 1985-09-27 | 1987-10-27 | Cambridge Instruments Inc. | Ocular scattering analyzer |
US5042494A (en) * | 1985-11-13 | 1991-08-27 | Alfano Robert R | Method and apparatus for detecting cancerous tissue using luminescence excitation spectra |
DE3542167A1 (en) * | 1985-11-29 | 1987-06-04 | Wolfgang Prof Dr Lohmann | METHOD FOR MEASURING THE EYE LENS TURBIDITY AND ARRANGEMENT FOR IMPLEMENTING THE METHOD |
CH671329A5 (en) * | 1986-01-21 | 1989-08-31 | Interzeag Ag | |
JPS62266032A (en) * | 1986-05-12 | 1987-11-18 | 興和株式会社 | Eyeground examination apparatus |
JPS6399836A (en) * | 1986-05-19 | 1988-05-02 | 興和株式会社 | Opthalmic measuring method and apparatus |
JPS63135128A (en) * | 1986-11-27 | 1988-06-07 | 興和株式会社 | Ophthalmic measuring apparatus |
JPH06100B2 (en) * | 1987-03-31 | 1994-01-05 | 興和株式会社 | Ophthalmic diagnostic device |
JP2520418B2 (en) * | 1987-04-09 | 1996-07-31 | 興和株式会社 | Ophthalmic measuring device |
US4877322A (en) * | 1987-04-30 | 1989-10-31 | Eyedentify, Inc. | Method and apparatus for measuring blood oxygen levels in selected areas of the eye fundus |
EP0292216B1 (en) * | 1987-05-20 | 1993-11-03 | Kowa Co. Ltd. | Ophthalmic disease detection apparatus |
US4842401A (en) * | 1987-06-15 | 1989-06-27 | The Board Of Trustees Of The Leland Stanford Jr. University | Eye diagnosis process |
JP2516631B2 (en) * | 1987-06-18 | 1996-07-24 | 興和株式会社 | Ophthalmic measuring device |
DE3851183D1 (en) * | 1987-06-25 | 1994-09-29 | Kowa Co | Method and device for the diagnosis of eye disorders. |
DD261957A1 (en) * | 1987-07-13 | 1988-11-16 | Friedrich Schiller Uni Jena Bf | ARRANGEMENT FOR CATARAFRUIT DIAGNOSTICS |
JPS6417623A (en) * | 1987-07-14 | 1989-01-20 | Kowa Co | Alignment apparatus in opthalmic apparatus |
JP2520426B2 (en) * | 1987-07-15 | 1996-07-31 | 興和株式会社 | Ophthalmic measuring device |
US5072731A (en) * | 1987-09-01 | 1991-12-17 | Massachusetts Institute Of Technology | Apparatus for detecting cataractogenesis using quasielastic light scattering |
US4993827A (en) * | 1987-09-01 | 1991-02-19 | Massachusetts Institute Of Technology | Method for detecting cataractogenesis |
US4957113A (en) * | 1987-09-01 | 1990-09-18 | Massachusetts Institute Of Technology | Method for detecting cataractogenesis using quasi-elastic light scattering |
US4832483A (en) * | 1987-09-03 | 1989-05-23 | New England Medical Center Hospitals, Inc. | Method of using resonance raman spectroscopy for detection of malignancy disease |
US4836207A (en) * | 1987-09-09 | 1989-06-06 | The Beth Israel Hospital Association | Method and apparatus to monitor cholesterol levels with photon correlation spectroscopy |
JPS6469925A (en) * | 1987-09-11 | 1989-03-15 | Hitachi Cable | Optical fiber type temperature distribution measuring apparatus |
US4882492A (en) * | 1988-01-19 | 1989-11-21 | Biotronics Associates, Inc. | Non-invasive near infrared measurement of blood analyte concentrations |
US5137355A (en) * | 1988-06-08 | 1992-08-11 | The Research Foundation Of State University Of New York | Method of imaging a random medium |
JPH02119837A (en) * | 1988-10-28 | 1990-05-07 | Kowa Co | Method and device for ophthalmologic measurement |
DD298677A5 (en) * | 1989-11-16 | 1992-03-05 | ��������`������������@�������@�������@M�������]k�� | METHOD FOR DETERMINING THE VOLUME FLOW |
JP2994703B2 (en) * | 1990-07-23 | 1999-12-27 | 興和株式会社 | Ophthalmic measurement device |
US5186173A (en) * | 1990-08-14 | 1993-02-16 | Drexel University | Method for in vivo measurement of oxygen concentration levels |
US5139022A (en) * | 1990-10-26 | 1992-08-18 | Philip Lempert | Method and apparatus for imaging and analysis of ocular tissue |
US5243983A (en) * | 1990-12-14 | 1993-09-14 | Georgia Tech Research Corporation | Non-invasive blood glucose measurement system and method using stimulated raman spectroscopy |
US5279296A (en) * | 1991-01-04 | 1994-01-18 | Oculon Corporation | Method and apparatus for detecting cataractogenesis |
US5219400A (en) * | 1991-06-11 | 1993-06-15 | The United States Of America As Represented By The Secretary Of The Army | Noninvasive method for quantitation of oxyhemoglobin saturation by near-infrared reflectance spectrophotometry |
US5203328A (en) * | 1991-07-17 | 1993-04-20 | Georgia Tech Research Corporation | Apparatus and methods for quantitatively measuring molecular changes in the ocular lens |
JPH07508426A (en) * | 1991-10-17 | 1995-09-21 | サイエンティフィック ジェネリクス リミテッド | Blood sample measuring device and method |
US5348018A (en) * | 1991-11-25 | 1994-09-20 | Alfano Robert R | Method for determining if tissue is malignant as opposed to non-malignant using time-resolved fluorescence spectroscopy |
US5284149A (en) * | 1992-01-23 | 1994-02-08 | Dhadwal Harbans S | Method and apparatus for determining the physical characteristics of ocular tissue |
US5340991A (en) * | 1993-05-21 | 1994-08-23 | The Board Of Regents Of The University Of Oklahoma | Fluorokinetic analysis of diffusion from a vessel |
-
1991
- 1991-07-17 US US07/731,533 patent/US5203328A/en not_active Expired - Lifetime
-
1992
- 1992-07-16 ES ES92916422T patent/ES2110007T3/en not_active Expired - Lifetime
- 1992-07-16 WO PCT/US1992/005941 patent/WO1993001745A1/en active IP Right Grant
- 1992-07-16 AU AU23733/92A patent/AU661026B2/en not_active Ceased
- 1992-07-16 CA CA002113268A patent/CA2113268C/en not_active Expired - Lifetime
- 1992-07-16 AT AT92916422T patent/ATE158704T1/en not_active IP Right Cessation
- 1992-07-16 EP EP92916422A patent/EP0597932B1/en not_active Expired - Lifetime
- 1992-07-16 DE DE69222535T patent/DE69222535T2/en not_active Expired - Lifetime
- 1992-07-16 JP JP5502944A patent/JPH07500030A/en not_active Expired - Lifetime
-
1993
- 1993-01-22 US US08/007,584 patent/US5582168A/en not_active Expired - Lifetime
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4548498A (en) * | 1981-05-04 | 1985-10-22 | Folestad Sven S | Laser induced fluorescence detection in modern liquid chromatography with conventional and micro columns |
US4592361A (en) * | 1982-06-28 | 1986-06-03 | The Johns Hopkins University | Electro-optical device and method for monitoring instantaneous singlet oxygen concentration produced during photoradiation using pulsed excitation and time domain signal processing |
US4883351A (en) * | 1982-09-10 | 1989-11-28 | Weiss Jeffrey N | Apparatus for the detection of diabetes and other abnormalities affecting the lens of the eye |
US4895159A (en) * | 1982-09-10 | 1990-01-23 | Weiss Jeffrey N | Diabetes detection method |
US4758081A (en) * | 1985-07-18 | 1988-07-19 | Bausch & Lomb Incorporated | Control of laser photocoagulation using Raman radiation |
US4675300A (en) * | 1985-09-18 | 1987-06-23 | The Board Of Trustees Of The Leland Stanford Junior University | Laser-excitation fluorescence detection electrokinetic separation |
Cited By (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994023284A1 (en) * | 1993-04-06 | 1994-10-13 | Cedar-Sinai Medical Center | Glucose fluorescence monitor and method |
EP0779508A3 (en) * | 1993-04-06 | 1998-03-11 | Cedars-Sinai Medical Center | Glucose fluorescence monitor and method |
EP0779508A2 (en) * | 1993-04-06 | 1997-06-18 | Cedars-Sinai Medical Center | Glucose fluorescence monitor and method |
WO1995022927A1 (en) * | 1994-02-23 | 1995-08-31 | Peyman Gholam A | Diagnostic system and method using an implanted reflective device |
US5701902A (en) * | 1994-09-14 | 1997-12-30 | Cedars-Sinai Medical Center | Spectroscopic burn injury evaluation apparatus and method |
WO1997013448A3 (en) * | 1995-10-14 | 1997-05-29 | Laser & Med Tech Gmbh | Device for determining blood glucose level |
WO1997013448A2 (en) * | 1995-10-14 | 1997-04-17 | Laser- Und Medizin-Technologie Gmbh Berlin | Device for determining blood glucose level |
WO1997020495A1 (en) * | 1995-12-01 | 1997-06-12 | Cedars-Sinai Medical Center | Glucose monitoring apparatus and method using laser-induced emission spectroscopy |
US6232609B1 (en) | 1995-12-01 | 2001-05-15 | Cedars-Sinai Medical Center | Glucose monitoring apparatus and method using laser-induced emission spectroscopy |
US7041063B2 (en) | 1996-09-04 | 2006-05-09 | Marcio Marc Abreu | Noninvasive measurement of chemical substances |
US7809417B2 (en) | 1996-09-04 | 2010-10-05 | Marcio Marc Abreu | Contact lens for collecting tears and detecting analytes for determining health status, ovulation detection, and diabetes screening |
US7756559B2 (en) | 1996-09-04 | 2010-07-13 | Marcio Marc Abreu | Device for generating a detectable signal based upon antibody/antigen interaction |
US8774885B2 (en) | 1996-09-04 | 2014-07-08 | Geelux Holdings, Ltd. | Device for generating a detectable signal based upon concentration of at least one substance |
US6681127B2 (en) | 1999-08-26 | 2004-01-20 | Novartis Ag | Ocular analyte sensor |
US6850786B2 (en) | 1999-08-26 | 2005-02-01 | Novartis Ag | Ocular analyte sensor |
WO2001013783A1 (en) * | 1999-08-26 | 2001-03-01 | Novartis Ag | Ocular analyte sensor |
AU767995B2 (en) * | 1999-08-26 | 2003-11-27 | Eyesense Ag | Ocular analyte sensor |
EP1229836A1 (en) * | 1999-11-05 | 2002-08-14 | SPECTRX, Inc. | Multi-modal optical tissue diagnostic system |
EP1229836A4 (en) * | 1999-11-05 | 2007-05-02 | Spectrx Inc | Multi-modal optical tissue diagnostic system |
US7403805B2 (en) | 2001-02-23 | 2008-07-22 | Marcio Marc Abreu | Apparatus and method for noninvasive measurement of analytes from the conjunctiva using mid-infrared radiation |
US8914089B2 (en) | 2001-02-23 | 2014-12-16 | Geelux Holdings, Ltd. | Noninvasive measurement of chemical substances |
US9398856B2 (en) | 2002-04-22 | 2016-07-26 | Geelux Holdings, Ltd. | Thermal imaging system |
US7187960B2 (en) | 2002-04-22 | 2007-03-06 | Marcio Marc Abreu | Apparatus and method for measuring biologic parameters |
US8721562B2 (en) | 2002-04-22 | 2014-05-13 | Geelux Holdings, Ltd. | Apparatus and method for measuring biologic parameters |
US10729371B2 (en) | 2002-04-22 | 2020-08-04 | Geelux Holdings Ltd. | Apparatus and method for measuring biologic parameters |
US11045092B2 (en) | 2002-04-22 | 2021-06-29 | Geelux Holdings, Ltd. | Apparatus and method for measuring biologic parameters |
US8849379B2 (en) | 2002-04-22 | 2014-09-30 | Geelux Holdings, Ltd. | Apparatus and method for measuring biologic parameters |
US9848815B2 (en) | 2002-04-22 | 2017-12-26 | Geelux Holdings, Ltd. | Apparatus and method for measuring biologic parameters |
US9011349B2 (en) | 2002-04-22 | 2015-04-21 | Geelux Holdings, Ltd. | Apparatus and method for measuring biologic parameters |
US10052030B2 (en) | 2002-04-22 | 2018-08-21 | Geelux Holdings, Ltd. | Apparatus and method for measuring biologic parameters |
US9301719B2 (en) | 2002-04-22 | 2016-04-05 | Geelux Holding, Ltd. | Apparatus and method for measuring biologic parameters |
US9833150B2 (en) | 2002-04-22 | 2017-12-05 | Geelux Holdings, Ltd. | Apparatus and method for measuring biologic parameters |
US9408572B2 (en) | 2002-04-22 | 2016-08-09 | Geelux Holdings, Ltd. | Apparatus and method for measuring biologic parameters |
US10123732B2 (en) | 2002-04-22 | 2018-11-13 | Geelux Holdings, Ltd. | Apparatus and method for measuring biologic parameters |
US8834020B2 (en) | 2003-04-22 | 2014-09-16 | Geelux Holdings, Ltd. | Thermal imaging system |
US8328420B2 (en) | 2003-04-22 | 2012-12-11 | Marcio Marc Abreu | Apparatus and method for measuring biologic parameters |
US10227063B2 (en) | 2004-02-26 | 2019-03-12 | Geelux Holdings, Ltd. | Method and apparatus for biological evaluation |
US10448890B2 (en) | 2005-10-24 | 2019-10-22 | Geelux Holdings, Ltd. | Apparatus and method for measuring biologic parameters |
US9445767B2 (en) | 2005-10-24 | 2016-09-20 | Geelux Holdings, Ltd. | Apparatus and method for measuring biologic parameters |
US9119530B2 (en) | 2005-10-24 | 2015-09-01 | Geelux Holdings, Ltd. | Apparatus and method for measuring biologic parameters |
WO2009083159A1 (en) * | 2007-12-21 | 2009-07-09 | Carl Zeiss Meditec Ag | Device and method for detection of molecules in the eye |
JP2014504169A (en) * | 2010-11-05 | 2014-02-20 | フリーダム メディテック インコーポレイテッド | Improved algorithm for diabetes detection |
US11497405B2 (en) | 2013-10-11 | 2022-11-15 | Brain Tunnelgenix Technologies Corp. | Method and apparatus for biological evaluation |
US10251776B2 (en) | 2014-01-10 | 2019-04-09 | Geelux Holding, Ltd. | Devices configured to monitor biological parameters, and to provide treatment, at an Abreu brain thermal tunnel |
US10335040B2 (en) | 2014-01-10 | 2019-07-02 | Geelux Holdings, Ltd. | Device for measuring the infrared output of the Abreu brain thermal tunnel |
US11963742B2 (en) | 2014-01-10 | 2024-04-23 | Brain Tunnelgenix Technologies Corp. | Device for measuring the infrared output of the Abreu brain thermal tunnel |
US11786394B2 (en) | 2014-01-10 | 2023-10-17 | Brain Tunnelgenix Technologies Corp. | Devices configured to monitor biological parameters, and to provide treatment, at an Abreu brain thermal tunnel |
US10383525B2 (en) | 2014-01-10 | 2019-08-20 | Geelux Holdings, Ltd. | Device for measuring the infrared output of the Abreu brain thermal tunnel |
US11331461B2 (en) | 2014-01-22 | 2022-05-17 | Brain Tunnelgenix Technologies Corp. | Devices configured to provide treatment at an Abreu brain thermal tunnel |
US10238847B2 (en) | 2014-01-22 | 2019-03-26 | Geelux Holdings, Ltd. | Devices and methods for transdermal drug delivery |
US9453794B2 (en) | 2014-09-29 | 2016-09-27 | Zyomed Corp. | Systems and methods for blood glucose and other analyte detection and measurement using collision computing |
US9459203B2 (en) | 2014-09-29 | 2016-10-04 | Zyomed, Corp. | Systems and methods for generating and using projector curve sets for universal calibration for noninvasive blood glucose and other measurements |
US9610018B2 (en) | 2014-09-29 | 2017-04-04 | Zyomed Corp. | Systems and methods for measurement of heart rate and other heart-related characteristics from photoplethysmographic (PPG) signals using collision computing |
US9448165B2 (en) | 2014-09-29 | 2016-09-20 | Zyomed Corp. | Systems and methods for control of illumination or radiation collection for blood glucose and other analyte detection and measurement using collision computing |
US9448164B2 (en) | 2014-09-29 | 2016-09-20 | Zyomed Corp. | Systems and methods for noninvasive blood glucose and other analyte detection and measurement using collision computing |
US9459201B2 (en) | 2014-09-29 | 2016-10-04 | Zyomed Corp. | Systems and methods for noninvasive blood glucose and other analyte detection and measurement using collision computing |
US9442065B2 (en) | 2014-09-29 | 2016-09-13 | Zyomed Corp. | Systems and methods for synthesis of zyotons for use in collision computing for noninvasive blood glucose and other measurements |
US9459202B2 (en) | 2014-09-29 | 2016-10-04 | Zyomed Corp. | Systems and methods for collision computing for detection and noninvasive measurement of blood glucose and other substances and events |
US11872018B2 (en) | 2015-03-10 | 2024-01-16 | Brain Tunnelgenix Technologies Corp. | Devices, apparatuses, systems, and methods for measuring temperature of an ABTT terminus |
US9554738B1 (en) | 2016-03-30 | 2017-01-31 | Zyomed Corp. | Spectroscopic tomography systems and methods for noninvasive detection and measurement of analytes using collision computing |
Also Published As
Publication number | Publication date |
---|---|
US5203328A (en) | 1993-04-20 |
ATE158704T1 (en) | 1997-10-15 |
EP0597932A1 (en) | 1994-05-25 |
ES2110007T3 (en) | 1998-02-01 |
EP0597932B1 (en) | 1997-10-01 |
EP0597932A4 (en) | 1994-12-07 |
JPH07500030A (en) | 1995-01-05 |
AU661026B2 (en) | 1995-07-13 |
US5582168A (en) | 1996-12-10 |
CA2113268C (en) | 1999-01-12 |
DE69222535T2 (en) | 1998-03-26 |
DE69222535D1 (en) | 1997-11-06 |
CA2113268A1 (en) | 1993-02-04 |
AU2373392A (en) | 1993-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU661026B2 (en) | Measuring molecular change in the ocular lens | |
JP6188225B2 (en) | A method for displaying predicted and measured values so that the predicted values and measured values are compared to determine a disease state | |
US4998533A (en) | Apparatus and method for in vivo analysis of red and white blood cell indices | |
US4883351A (en) | Apparatus for the detection of diabetes and other abnormalities affecting the lens of the eye | |
JP3679800B2 (en) | Glucose fluorescence test method | |
JP4621496B2 (en) | Line scan ophthalmoscope | |
US5042494A (en) | Method and apparatus for detecting cancerous tissue using luminescence excitation spectra | |
US6088606A (en) | Method and apparatus for determining a duration of a medical condition | |
US5072731A (en) | Apparatus for detecting cataractogenesis using quasielastic light scattering | |
US5540226A (en) | Apparatus for detecting cataractogenesis | |
US5025785A (en) | Diabetes detection method | |
US4993827A (en) | Method for detecting cataractogenesis | |
US4922919A (en) | Method for measuring ocular oxidative metabolism | |
Rovati et al. | Autofluorescence methods in ophthalmology | |
US4895159A (en) | Diabetes detection method | |
US4957113A (en) | Method for detecting cataractogenesis using quasi-elastic light scattering | |
Weiss et al. | Laser light scattering spectroscopy of in vivo human lenses. | |
Yu et al. | Development of a noninvasive diabetes screening device using the ratio of fluorescence to Rayleigh scattered light | |
WO1988000447A1 (en) | In vivo analysis of red blood cell indices | |
Weiss | Patents: Apparatus for the Detection of Diabetes and Other Abnormalities Affecting the Lens of the Eye | |
Weiss | Patents: Diabetes Detection Method# 1 | |
CA1326062C (en) | Apparatus and method for detecting cataractogenesis | |
AU2015202762B2 (en) | Improved algorithm for detection of diabetes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU BB BG BR CA CS FI HU JP KP KR LK MG MN MW NO PL RO RU SD |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IT LU MC NL SE BF BJ CF CG CI CM GA GN ML MR SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1992916422 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2113268 Country of ref document: CA |
|
WWP | Wipo information: published in national office |
Ref document number: 1992916422 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1992916422 Country of ref document: EP |